IPO - Amesite Inc.

Form Type: 8-K

Filing Date: 2025-01-10

Corporate Action: Ipo

Type: New

Accession Number: 000121390025002639

Filing Summary: On January 7, 2025, Amesite Inc. entered into an underwriting agreement with Laidlaw & Company (UK) Ltd. to issue and sell 1,201,667 shares of its common stock at a price of $3.00 per share. This offering stemmed from its shelf registration statement effective December 18, 2024, and will be conducted on a best efforts basis. The Underwriting Agreement includes terms allowing for the issuance of Underwriters’ Warrants to purchase additional shares at an exercise price of $3.75. The Company also entered a 30-day lock-up period concerning sales of specified securities. The offering closed on January 8, 2025, resulting in approximately $3.6 million in gross proceeds and net proceeds of approximately $3.08 million after deducting expenses. Furthermore, the Company believes it has regained compliance with Nasdaq Listing Rule by surpassing the required stockholders’ equity after the offering.

Document Link: View Document